Table I. Demographics of patients undergoing revascularization for superficial femoral artery (SFA) occlusive disease.
Variablea | Bypass | SFA stent | P |
---|---|---|---|
Total patients | 141 | 204 | |
Total limbs | 152 | 233 | |
Age, years | 66 ± 22 (38-87) | 70 ± 11 (37-99) | .0013 |
Male sex | 101 (66) | 129 (55) | .0302 |
Indication | |||
Claudication | 70 (46) | 130 (56) | .0773 |
CLI | 82 (54) | 103 (44) | |
Diabetes | 64 (42) | 105 (45) | .5686 |
Creatinine >1.8 mg/dL | 17 (11) | 21 (9) | .5594 |
Hypertension | 115 (76) | 192 (82) | .0897 |
Hyperlipidemia | 105 (69) | 160 (69) | .9813 |
Statin use | 101 (66) | 106 (55) | .0197 |
Smoking | 75 (49) | 70 (30) | <.0001 |
CAD | 53 (35) | 110 (47) | .0165 |
TASC lesion | <.0001 | ||
A | 3 (2) | 41 (18) | |
B | 50 (33) | 145 (62) | |
C | 33 (22) | 32 (14) | |
D | 66 (43) | 15 (6) |
CAD, Coronary artery disease; CLI, critical limb ischemia; TASC, TransAtlantic Inter-Society Consensus.
Data are shown as number (%) or mean ± standard deviation (range).